目次

TABLE OF CONTENTS

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.2 RESTRAINTS
5.2.3 OPPORTUNITIES
5.2.4 CHALLENGES
5.3 TECHNOLOGY ANALYSIS
5.3.1 KEY TECHNOLOGY
5.3.2 COMPLIMENTARY TECHNOLOGY
5.3.3 ADJACENT TECHNOLOGY
5.4 INDUSTRY TRENDS
5.5 SUPPLY CHAIN ANALYSIS
5.6 TRADE ANALYSIS
5.7 PORTER'S FIVE FORCE ANALYSIS
5.8 TARIFF AND REGULATORY LANDSCAPE
5.8.1 REGULATORY ANALYSIS
5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATION
5.9 PATENT ANALYSIS
5.10 PRICING ANALYSIS
5.10.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TYPE
5.10.2 AVERAGE SELLING PRICE TREND BY REGION
5.11 KEY CONFERENCES & EVENTS DURING 2023-2024
5.12 KEY STAKEHOLDERS & BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS & BUYING PROCESS
5.12.2 BUYING CRITERIA
5.13 ECOSYSTEM/MARKET MAP
5.14 ADJACENT MARKET ANALYSIS
5.15 CASE STUDY ANALYSIS
5.16 REIMBUSREMENT SCENARIO
5.17 VALUE CHAIN ANALYSIS
5.18 TRENDS/DISRUPTION IMPACTING CUSTOMER’S BUSINESS
5.19 UNMET NEEDS/END-USER EXPECTATIONS IN OXYGEN CONCENTRATORS

6 OXYGEN CONCENTRATORS MARKET, BY TYPE, 2022-2030 (USD MILLION)
6.1 INTRODUCTION
6.2 PORTABLE
6.3 STATIONARY

7 OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
7.1 INTRODUCTION
7.2 CONTINUOUS FLOW
7.3 PULSE FLOW

8 OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
8.1 INTRODUCTION
8.2 CHRONIC OBSTRUCTIVE PULMONARY DISORDER
8.3 ASTHMA
8.4 RESPIRATORY DISTRESS
8.5 OTHERS (SLEEP APNEA, INTERSTITIAL LUNG DISEASE, INTERSTITIAL FIBROSIS, CYSTIC FIBROSIS OF LUNGS, POST-OPERATIVE CARE, ETC.)

9 OXYGEN CONCENTRATORS MARKET, BY END-USER, 2022-2030 (USD MILLION)
9.1 INTRODUCTION
9.2 HOSPITALS AND CLINICS
9.3 HOME CARE SETTINGS
9.4 AMBULATORY SURGICAL CENTERS AND PHYSICIANS’ OFFICES

10 OXYGEN CONCENTRATORS MARKET, BY REGION, 2022-2030 (USD MILLION)
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
10.2.2 US
10.2.3 CANADA
10.3 EUROPE
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
10.3.2 GERMANY
10.3.3 FRANCE
10.3.4 UK
10.3.5 ITALY
10.3.6 SPAIN
10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
10.4.2 JAPAN
10.4.3 CHINA
10.4.4 AUSTRALIA
10.4.5 INDIA
10.4.6 SOUTH KOREA
10.4.7 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
10.5.2 BRAZIL
10.5.3 MEXICO
10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
10.7 GCC COUNTRIES
10.7.1 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES

11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN
11.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
11.4 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
11.4.1 STARS
11.4.2 EMERGING LEADERS
11.4.3 PERVASIVE PLAYERS
11.4.4 PARTICIPANTS
11.4.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
11.4.5.1 COMPANY FOOTPRINT
11.4.5.2 REGION FOOTPRINT
11.4.5.3 TYPE FOOTPRINT
11.4.5.4 TECHNOLOGY FOOTPRINT
11.4.5.5 APPLICATION FOOTPRINT
11.4.5.6 END-USER FOOTPRINT
11.5 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
11.5.1 PROGRESSIVE COMPANIES
11.5.2 RESPONSIVE COMPANIES
11.5.3 DYNAMIC COMPANIES
11.5.4 STARTING BLOCKS
11.5.5 COMPETITIVE BENCHMARKING: STARTUPS/SME, 2023
11.5.5.1 DETAILED LIST OF KEY STARTUPS/SMES
11.5.5.2 COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
11.6 BRAND/PRODUCT COMPARATIVE ANALYSIS
11.7 MARKET SHARE ANALYSIS
11.8 COMPETITIVE SITUATION AND TRENDS
11.8.1 PRODUCT LAUNCHES & APPROVALS
11.8.2 DEALS
11.8.3 OTHER DEVELOPMENTS
11.9 R&D ASSESSMENT OF KEY PLAYERS
11.10 VALUATION AND FINANCIAL METRICS OF KEY PLAYERS IN OXYGEN CONCENTRATORS MARKET

12 COMPANY PROFILE
12.1 KEY PLAYERS
12.1.1 KONINKLIJKE PHILIPS N.V.
12.1.2 CHART INDUSTRIES, INC. (AIRSEP)

12 1.3 INOGEN, INC.
12.1.4 INVACARE CORPORATION
12.1.5 DEVILBISS HEALTHCARE LLC.
12.1.6 NIDEK MEDICAL PRODUCTS, INC.
12.1.7 GCE GROUP
12.1.8 SUPERA ANASTHESIA INNOVATIONS
12.1.9 O2 CONCEPT LCC.
12.1.10 TEIJIN LIMITED
12.2 OTHER PLAYERS
12.2.1 DAIKIN INDUSTRIES, LTD.
12.2.2. YUWELL
12.2.3 BPL MEDICAL TECHNOLOGIES
12.2.4 OXYMED
12.2.5 ELOXY TECHNOLOGY
12.2.6 EQUINOX
12.2.7 GVS
12.2.8 MESSE DUSSELDORF GMBH
12.2.9. AIR LIQUIDE HEALTHCARE
12.2.10 INSPIRE SLEEP
12.2.11 CANADA CPAP SUPPLY
12.2.12 KALSTEIN
12.2.13 NOXERIOR S.R.L
12.2.14 PURE O2
12.2.15 EVOS

13 APPENDIX
13.1 INSIGHTS OF INDUSTRY EXPERTS
13.2 DISCUSSION GUIDE
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS

*Contents in the ToC/market segments are tentative and might change as the research proceeds.

*List of companies is not exhaustive and might change during course of study.

*Details on key financials might not be captured in case of unlisted companies.